Les nouveaux marqueurs biologiques du cancer de la prostate

25 mars 2011

Auteurs : Th. Bessede
Référence : Prog Urol, 2011, 21, S63, suppl. S2




 



Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser



Références



Mazzola C.R., Ghoneim T., Shariat S.F. Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer Prog Urol 2011 ;  21 : 1-10 [cross-ref]
Graves H.C., Sensabaugh G.F., Blake E.T. Postcoital detection of a male-specific semen protein. Application to the investigation of rape N Engl J Med 1985 ;  312 : 338-343 [cross-ref]
Benson M.C., Whang I.S., Pantuck A., Ring K., Kaplan S.A., Olsson C.A., et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer J Urol 1992 ;  147 : 815-816 [cross-ref]
Sengupta S., Slezak J.M., Blute M.L., Bergstralh E.J. Simple graphic method for estimation of prostate-specific antigen doubling time Urology 2006 ;  67 : 408-409 [inter-ref]
MSKCC. Prostate Cancer Nomograms. PsaDoublingTimeaspx; 2006.
Vickers A.J., Savage C., O’Brien M.F., Lilja H. Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer J Clin Oncol 2009 ;  27 : 398-403 [cross-ref]
Thompson I.M., Ankerst D.P., Chi C., Goodman P.J., Tangen C.M., Lucia M.S., et al. Assessing prostate cancer risk:results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 2006 ;  98 : 529-534 [cross-ref]
Parekh D.J., Ankerst D.P., Higgins B.A., Hernandez J., Canby-Hagino E., Brand T., et al. External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population Urology 2006 ;  68 : 1152-1155 [inter-ref]
Thompson IM. The New PCPT Prostate Cancer Calculator. calcsPCA3jsp; 2010.
Benchikh El Fegoun A., Villers A. Molecular forms of PSA Prog Urol 2007 ;  17 : 165-171 [inter-ref]
Catalona W.J., Southwick P.C., Slawin K.M., Partin A.W., Brawer M.K., Flanigan R.C., et al. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging Urology 2000 ;  56 : 255-260 [inter-ref]
Catalona WJ, Sanda MG, Wel JT, Klee GG, Slawin KM, Marks LS et al. ProPSA in combination with PSA and free-PSA, using the Beckman coulter access immunoassay systems improves prostate cancer detection relative to PSA and free PSA. A multi-center prospective clinical study. J of Urology 2010;183:in press .
Jansen FH, van Schaik RH, Kurstjens J, Horninger W, Klocker H, Bektic J, et al. Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection. Eur Urol 2010;in press .
Bussemakers M.J., van Bokhoven A., Verhaegh G.W., Smit F.P., Karthaus H.F., Schalken J.A., et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer Cancer Res 1999 ;  59 : 5975-5979
Vlaeminck-Guillem V., Ruffion A., Andre J. Value of urinary PCA3 test for prostate cancer diagnosis Prog Urol 2008 ;  18 : 259-265 [inter-ref]
Reynolds M.A., Kastury K., Groskopf J., Schalken J.A., Rittenhouse H. Molecular markers for prostate cancer Cancer Lett 2007 ;  249 : 5-13 [cross-ref]
de Kok J.B., Verhaegh G.W., Roelofs R.W., Hessels D., Kiemeney L.A., Aalders T.W., et al. DD3 (PCA3), a very sensitive and specific marker to detect prostate tumors Cancer Res 2002 ;  62 : 2695-2698
Deras I.L., Aubin S.M., Blase A., Day J.R., Koo S., Partin A.W., et al. PCA3: a molecular urine assay for predicting prostate biopsy outcome J Urol 2008 ;  179 : 1587-1592 [cross-ref]
Durand X., Xylinas E., Ploussard G., De la Taille A. Urinary biomarkers in prostate cancer: an update Prog Urol 2010 ;  20 : 1184-1191 [inter-ref]
Tomlins S.A., Rhodes D.R., Perner S., Dhanasekaran S.M., Mehra R., Sun X.W., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 2005 ;  310 : 644-648 [cross-ref]
Beuzeboc P., Soulie M., Richaud P., Salomon L., Staerman F., Peyromaure M., et al. Fusion genes and prostate cancer. From discovery to prognosis and therapeutic perspectives Prog Urol 2009 ;  19 : 819-824 [inter-ref]
Rice K.R., Chen Y., Ali A., Whitman E.J., Blase A., Ibrahim M., et al. Evaluation of the ETS-related gene mRNA in urine for the detection of prostate cancer Clin Cancer Res 2010 ;  16 : 1572-1576 [cross-ref]






© 2011 
Elsevier Masson SAS. Tous droits réservés.